1. Home
  2. KEQU vs GOSS Comparison

KEQU vs GOSS Comparison

Compare KEQU & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KEQU
  • GOSS
  • Stock Information
  • Founded
  • KEQU 1906
  • GOSS 2015
  • Country
  • KEQU United States
  • GOSS United States
  • Employees
  • KEQU N/A
  • GOSS N/A
  • Industry
  • KEQU Medical Specialities
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • KEQU Industrials
  • GOSS Health Care
  • Exchange
  • KEQU Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • KEQU 183.8M
  • GOSS 212.8M
  • IPO Year
  • KEQU N/A
  • GOSS 2019
  • Fundamental
  • Price
  • KEQU $54.62
  • GOSS $1.40
  • Analyst Decision
  • KEQU
  • GOSS Strong Buy
  • Analyst Count
  • KEQU 0
  • GOSS 5
  • Target Price
  • KEQU N/A
  • GOSS $9.20
  • AVG Volume (30 Days)
  • KEQU 23.5K
  • GOSS 1.6M
  • Earning Date
  • KEQU 03-05-2025
  • GOSS 03-04-2025
  • Dividend Yield
  • KEQU N/A
  • GOSS N/A
  • EPS Growth
  • KEQU 168.79
  • GOSS N/A
  • EPS
  • KEQU 6.31
  • GOSS N/A
  • Revenue
  • KEQU $199,637,000.00
  • GOSS $105,322,000.00
  • Revenue This Year
  • KEQU N/A
  • GOSS N/A
  • Revenue Next Year
  • KEQU N/A
  • GOSS N/A
  • P/E Ratio
  • KEQU $9.14
  • GOSS N/A
  • Revenue Growth
  • KEQU N/A
  • GOSS N/A
  • 52 Week Low
  • KEQU $27.00
  • GOSS $0.50
  • 52 Week High
  • KEQU $71.33
  • GOSS $1.60
  • Technical
  • Relative Strength Index (RSI)
  • KEQU 36.81
  • GOSS 67.09
  • Support Level
  • KEQU $55.00
  • GOSS $1.37
  • Resistance Level
  • KEQU $71.33
  • GOSS $1.55
  • Average True Range (ATR)
  • KEQU 3.56
  • GOSS 0.13
  • MACD
  • KEQU -1.42
  • GOSS 0.03
  • Stochastic Oscillator
  • KEQU 0.00
  • GOSS 75.81

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: